Vanguard Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Vanguard Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,442,171	Closed	-$249M	–	4251
2015 Q1	$249M	Sell	1,442,171 -2,342,138	-62%	-$344M	0.02%	916
2014 Q4	$435M	Buy	3,784,309 +135,571	+4%	+$16.4M	0.03%	604
2014 Q3	$570M	Sell	3,648,738 -261,616	-7%	-$37.9M	0.04%	470
2014 Q2	$482M	Sell	3,910,354 -210,223	-5%	-$23.2M	0.04%	531
2014 Q1	$427M	Buy	4,120,577 +539,834	+15%	+$55.3M	0.04%	554
2013 Q4	$322M	Buy	3,580,743 +86,777	+2%	+$6.92M	0.03%	645
2013 Q3	$234M	Sell	3,493,966 -1,535	-0%	-$106K	0.02%	760
2013 Q2	$231M	Buy	+3,495,501	New	+$200M	0.02%	712

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Vanguard Group's SLXP Position: Q2 2015 in Review

Vanguard Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,442,171 shares — an estimated $249M sold.

Vanguard Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $570M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Vanguard Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Vanguard Group sold 1,442,171 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $249M.
Vanguard Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Vanguard Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $570M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.